IPO registrations (S-1, F-1) · Registrants
REPROS THERAPEUTICS INC.
- SEC CIK
- 897075 · filings on EDGAR ↗
- Former names
- REPROS THERAPEUTICS INC (2006–2006); ZONAGEN INC (1996–2006)
- Registration
- Form S-1, first filed 2004-10-20, last 2011-12-19; 3 initial registrations, 5 amendments
- Outcome
- Final prospectus filed 2005-01-27; declared effective 2006-09-15; withdrawal requested 2012-01-13
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 2408 TIMBERLOCH PL, SUITE B-7, Woodlands, TX 77380
- EIN
- 76-0233274
- EDGAR entity type
- operating
- Insiders and CEO pay
- REPROS THERAPEUTICS INC. on the corporate pages
Offering terms
- Final price
- $4.00 per share (424B4 filed 2005-01-27)
- Shares sold
- 4,400,000
- Gross proceeds
- $17,600,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ZONA
- Lead underwriters
- statement on Form S-1 under the Securities Act of (1,933 shares); December 31, September 30 (2,003 shares); Marketable securities (2,000 shares)
- Syndicate
- Punk, Ziegel & Company; Note receivable — (1,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: REPROS THERAPEUTICS INC EXACT (CIK (EXACT))
- Person page: Jeffrey R Harder Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Jon Faiz Kayyem Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
Filings 21
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2004-10-20 | S-1 | S-1 (registration) | ZONAGEN INC | 0000950129-04-007913 ↗ |
| 2004-12-01 | S-1/A | S-1/A (amendment) | ZONAGEN INC | 0000950129-04-009454 ↗ |
| 2004-12-17 | S-1/A | S-1/A (amendment) | ZONAGEN INC | 0000950129-04-009896 ↗ |
| 2005-01-13 | S-1/A | S-1/A (amendment) | ZONAGEN INC | 0000950134-05-000646 ↗ |
| 2005-01-24 | S-1/A | S-1/A (amendment) | ZONAGEN INC | 0000950129-05-000521 ↗ |
| 2005-01-27 | S-1MEF | S-1MEF (added securities) | ZONAGEN INC | 0000950134-05-001391 ↗ |
| 2005-01-27 | 424B4 | 424B4 (final prospectus) | ZONAGEN INC | 0000950134-05-001413 ↗ |
| 2006-09-15 | EFFECT | EFFECT (declared effective) | REPROS THERAPEUTICS INC. | 9999999995-06-001543 ↗ |
| 2008-11-26 | EFFECT | EFFECT (declared effective) | REPROS THERAPEUTICS INC. | 9999999995-08-003523 ↗ |
| 2010-01-07 | EFFECT | EFFECT (declared effective) | REPROS THERAPEUTICS INC. | 9999999995-10-000140 ↗ |
| 2010-01-08 | EFFECT | EFFECT (declared effective) | REPROS THERAPEUTICS INC. | 9999999995-10-000160 ↗ |
| 2010-06-25 | EFFECT | EFFECT (declared effective) | REPROS THERAPEUTICS INC. | 9999999995-10-001946 ↗ |
| 2010-12-15 | S-1 | S-1 (registration) | REPROS THERAPEUTICS INC. | 0001144204-10-066699 ↗ |
| 2011-02-02 | S-1/A | S-1/A (amendment) | REPROS THERAPEUTICS INC. | 0001144204-11-005372 ↗ |
| 2011-02-03 | EFFECT | EFFECT (declared effective) | REPROS THERAPEUTICS INC. | 9999999995-11-000341 ↗ |
| 2011-02-07 | 424B4 | 424B4 (final prospectus) | REPROS THERAPEUTICS INC. | 0001144204-11-006349 ↗ |
| 2011-12-19 | S-1 | S-1 (registration) | REPROS THERAPEUTICS INC. | 0001144204-11-070548 ↗ |
| 2012-01-13 | RW | RW (withdrawal request) | REPROS THERAPEUTICS INC. | 0001144204-12-002197 ↗ |
| 2012-08-22 | EFFECT | EFFECT (declared effective) | REPROS THERAPEUTICS INC. | 9999999995-12-002562 ↗ |
| 2012-10-10 | EFFECT | EFFECT (declared effective) | REPROS THERAPEUTICS INC. | 9999999995-12-002952 ↗ |
| 2012-10-25 | EFFECT | EFFECT (declared effective) | REPROS THERAPEUTICS INC. | 9999999995-12-003088 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2005-01-13 | S-1/A | registration statement | 4,000,000 | - | Nasdaq ZONA | 5 | primary document; shares headline, underwriting table 4, cover names 1 | document ↗ | ||
| 2005-01-24 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2005-01-27 | 424B4 | final prospectus | $4.00 | 4,400,000 | $17,600,000 | Nasdaq ZONA | 5 | primary document; price table, shares headline, proceeds table, underwriting table 4, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| PODOLSKI JOSEPH | Director,Officer | Chief Executive Officer; President and CEO | 35 | 2006–2016 | |
| CAIN DANIEL F | Director | 21 | 2006–2018 | ||
| FOURCROY JEAN L MD PHD MPH | Director | 10 | 2006–2012 | ||
| Harder Jeffrey R | Director | 12 | 2006–2008 | person page Fuzzy | |
| Masterson Nola E | Director | 25 | 2006–2018 | ||
| Poorvin David | Director | 3 | 2006–2008 | ||
| PLOTH LOUIS JR | Director,Officer | VP & Chief Financial Officer | 8 | 2006–2009 | |
| van As Andre MD, PhD | Officer | Chief Medical Officer | 6 | 2006–2009 | |
| Wiehle Ronald | Officer | Vice President, R&D; VP, Research and Development | 11 | 2007–2014 | |
| Efficacy Biotech Master Fund Ltd. | TenPercentOwner | 24 | 2007–2009 | ||
| Efficacy Capital, Ltd. | TenPercentOwner | 24 | 2007–2009 | ||
| Kayyem Jon Faiz | TenPercentOwner | 20 | 2007–2008 | person page Fuzzy | |
| Lappe Mark | Director,TenPercentOwner; TenPercentOwner | 34 | 2007–2009 | ||
| Efficacy Biotech Fund L.P. | TenPercentOwner | 23 | 2007–2009 | ||
| Efficacy Biotech Fund LTD | TenPercentOwner | 23 | 2007–2009 | ||
| REED JOHN C | Director | 7 | 2008–2009 | ||
| Lammers Paul | Officer | President | 2 | 2009 | |
| Howell Stephen B. | Director | 2 | 2009 | ||
| Anderson Katherine | Officer | Chief Accounting Officer; Chief Financial Officer; CHIEF FINANCIAL OFFICER | 22 | 2009–2018 | |
| Thompson Jaye | Director; Director,Officer; Officer | See Remarks; Senior Vice President | 8 | 2009–2016 | |
| PERCEPTIVE ADVISORS LLC | TenPercentOwner | 26 | 2011–2013 | ||
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | TenPercentOwner | 26 | 2011–2013 | ||
| Oliveira Steven Michael | TenPercentOwner | 1 | 2011 | ||
| EDELMAN JOSEPH | TenPercentOwner | 20 | 2011–2013 | ||
| Wyllie Michael | Director | 13 | 2011–2018 | ||
| Wernicke J. F. | Officer | Chief Medical Officer | 3 | 2013–2016 | |
| Ramasastry Saira | Director | 9 | 2013–2018 | ||
| Suesserman Michael | Director | 4 | 2014–2015 | ||
| FOURTEAU PATRICK | Director; Director,Officer | President and CEO | 6 | 2016–2018 | |
| Dillaha Larry | Officer | Interim President and CEO | 1 | 2017 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Patent assignee | REPROS THERAPEUTICS INC. | TX | Patents (USPTO) | name and state |
| SEC filer | REPROS THERAPEUTICS INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Repros Therapeutics Inc. | TX | Trademarks (USPTO) | name and state |
| Person page | Jeffrey R Harder | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Jon Faiz Kayyem | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), TX first:
- ILEX ONCOLOGY INC TX
- HEMOBIOTECH, INC. TX
- Peloton Therapeutics, Inc. TX
- Alpha Cognition Inc. TX
- Instil Bio, Inc. TX
- Kiromic Biopharma, Inc. TX
- Taysha Gene Therapies, Inc. TX
- CG Oncology, Inc. TX
- Voyager Acquisition Corp./Cayman Islands TX
- STEM CELL INNOVATIONS, INC. TX
In other datasets, the same topic (Health) in TX:
- Nonprofit: AARON ALEXANDERS CLUB NICU (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health